SwingTrade Member Forum

[Rawnoc]

REPR is one of my favorite long term plays. They are already nicely profitable, growing, no dilution, an insider buying in the open market, their main product is the only one of their kind approved by medicare, and they have a nicely profitable recurring revenue stream.

REPR has a nice balance sheet with very little debt and a cash balance growing nicely. They have been hiring like crazy all year. Last but certainly not lease they got an FDA approval for a new product in May of this year and are launching sales for it in the current quarter after hiring a production team and stockpiling inventory last quarter.